Indeed, in a study of individuals with Dravet syndrome, one third of individuals who did not have a pathogenic mutation in SCN1A were found to harbor mutations in CHD2 [69]. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.